Viapath's Innovation Academy focuses on Next Generation Diagnostics Wednesday 12 November 2014 PDF Print Date: 5 December 2014 Time: 9.15am – 4.00pm Venue: Grocers’ Hall, Princes Street, London EC2R 8AD London, 12 November 2014, Viapath is pleased to announce its line-up of thought leaders and expert speakers for its upcoming fourth symposium of the Innovation Academy focusing on ‘Next Generation Diagnostics’. Attracting some of the most dynamic, influential and forward thinking protagonists who are driving and shaping the pathology agenda, these specially invited speakers will share insight into their work, and personal experiences and how leading developments in the next generation of diagnostic tools in pathology are improving lives for patients. Among the speakers will be the renowned vitamin K2 researcher, Professor Cees Vermeer from Maastricht University and Dr. Tim Spector, Director of the Department of Twin Research and Genetic Epidemiology at St Thomas’ Hospital, London. ‘We are delighted to welcome our speakers to this, our fourth Innovation Academy. This event is set to be a great success and with attendance rising every year it’s clear that the Innovation Academy offers an unprecedented opportunity for the profession to come together and share ideas around three founding principles of Innovation, Quality and Staff Development,” said Dr Dominic Harrington, Scientific Director at Viapath for Guy’s and St. Thomas’. Opening remarks will be made by writer, broadcaster and scientist, Vivienne Parry OBE from ‘The 100,000 Genomes Project’. The recently confirmed conference speaker line up is as follows: Time: 10.00 Session: Vascular vitamin K insufficiency: an independent risk factor for vascular calcification and mortality Speaker: Prof Cees Vermeer Maastricht University Time: 10.30 Session: Neurodevelopmental, neurodegenerative and neuromuscular disorders due to defects in membrane trafficking and autophagy Speaker: Dr Heinz Jungbluth, Evelina London Time: 11.00 Session: Steroid abuse in sport Speaker: Dr Andrew Kicman, Department of Forensic & Analytical Science at Kings College London Time: 11.50 Session: Development of NGS based neuro panels. Speaker: Dr Joo Wook Ahn, Viapath (Guy’s Hospital) Time: 12.05 Session: Application of nanopore sequencing in pre-implantation genetic diagnosis Speaker: Dr Kevin Ryan, Viapath (Guy’s Hospital) Time: 12.20 Session: Combined measurement of biogenic amines and their metabolites in plasma or urine using turbulent flow liquid chromatography-tandem mass spectrometry Speaker: Dr David Taylor, Viapath (King’s College Hospital) Time: 12.35 Session: Changes in serum steroid concentrations in relation to fat distribution and insulin resistance in women with PCOS. Speaker: Lea Ghataore, Viapath (King’s College Hospital) Time: 12.50 Session: Development of a high-resolution mass spectrometric immunoassay (MSIA) for human hepcidin. Speaker: Simon Handley Viapath (King’s College Hospital) Time: 2.15 Session: Targeted metabolomic approach to the diagnosis of inborn errors of metabolism using tandem mass spectrometry Speaker: Prof Neil Dalton, Professor of Paediatric Biochemistry at King’s College London Time: 2.45 Session: Circulating plasma micro-RNA - a next generation diagnostic? Speaker: Dr Tony Marinaki, Consultant Clinical Scientist, with an interest in Pharmacogenetics and Personalised Medicine, Viapath (St. Thomas’ Hospital). Time: 3.15 Session: Twins Omics and personalised medicine Speaker: Prof Tim Spector Consultant Rheumatologist Based at Dept. of Twin Research at Kings College London Time: 3.45 Session: Panel Discussion 4.00 Close This free to attend event is the perfect opportunity for those interested in Next Generation Diagnostics to meet, converse and network with key experts in this field. Attendees to the session will also be able to interact with the chair and speakers via the dedicated hashtag #innovationacademy Further information will be released in the coming week but in the meantime contact firstname.lastname@example.org if you would like to attend. www.viapath.co.uk/innovationacademy Editors Note Viapath Group was previously known as GSTS Pathology LLP and rebranded as Viapath on 1 May 2014. The organisation was created five years ago by Guy’s and St Thomas’ NHS Foundation Trust and Serco plc. Later in 2009, the joint venture won a contract to provide pathology services to Bedford Hospital NHS Trust. In 2010, King’s College Hospital NHS Foundation Trust became a member. Viapath is now majority owned by two leading teaching hospitals. The Innovation Academy was conceived to bring together the wide spectrum of resources, researchers, innovation and development within the field of pathology and to disseminate the outputs to the wider clinical and scientific community. It is a forum for communication based on three foundation principles – Innovation, Quality and Staff Development. Pathology is vital to health care and it is estimated that 70-80% of all health care decisions affecting diagnosis or treatment involve a pathology investigation. Viapath provides pathology services to over 400 NHS trusts, GP practices and private health clinics. With around 1,000 employees processing more than 22 million tests each year, the work of Viapath touches thousands of lives every day. For more information, visit Viapath or follow us on Twitter @ViapathUk Press Information Deirdre Cumberbatch|Viapath External Communications M: 07793 045 83 Francis House, 9 King’s Head Yard, London, SE1 1NA E: email@example.com Viapath This press release was distributed by ResponseSource Press Release Wire on behalf of Viapath LLP in the following categories: Health, Medical & Pharmaceutical, Public Sector, Third Sector & Legal, for more information visit http://pressreleasewire.responsesource.com/about.